Skip to main content
Premium Trial:

Request an Annual Quote

Pacific Biosciences: Mark Van Oene, Peter Fromen

Pacific Biosciences announced it has appointed Mark Van Oene to the newly created role of chief operating officer and Peter Fromen as chief commercial officer (CCO), both effective Jan. 8, 2021.

Van Oene joins PacBio after 15 years at Illumina, where he most recently served as senior VP and CCO and oversaw worldwide sales and service. He will be responsible for managing PacBio's research, development, and manufacturing organizations and for driving strategic planning and corporate development activities.

Fromen also joins from Illumina, where he most recently served as global VP of population genomics and precision health. Based in London since 2015, he oversaw Illumina's partnership with Genomics England and the National Health System. Fromen will be responsible for all commercial activity worldwide, including sales, marketing, and customer support.